Figures & data
Figure 1. Pictures of a bottle of medical quality CO2 (A) and of Veress needle connected with 60 ml syringe through a 3-way tap (B left) with zoomed view on the extremity of Veress needle (B right).
![Figure 1. Pictures of a bottle of medical quality CO2 (A) and of Veress needle connected with 60 ml syringe through a 3-way tap (B left) with zoomed view on the extremity of Veress needle (B right).](/cms/asset/33bbe9b1-b315-41fb-9213-3ec86b26712b/ihyt_a_1477206_f0001_c.jpg)
Figure 2. HCC (arrow) located in the dome (unvisible on US) on arterial T1-weighted MR image (A). PTA after HCC (arrow) tagging using lipiodol arterial injection and artificial CO2 pneumothorax (B). Follow-up 3 months after PTA showing the ablation zone (arrows) on subtraction T1-weighted MR image at the arterial phase (C).
![Figure 2. HCC (arrow) located in the dome (unvisible on US) on arterial T1-weighted MR image (A). PTA after HCC (arrow) tagging using lipiodol arterial injection and artificial CO2 pneumothorax (B). Follow-up 3 months after PTA showing the ablation zone (arrows) on subtraction T1-weighted MR image at the arterial phase (C).](/cms/asset/63eb57f7-7174-45dc-a2a0-ed559cb9aee9/ihyt_a_1477206_f0002_b.jpg)
Table 1. Characteristics of the 56 included patients with HCC located at the hepatic dome.
Table 2. Outcomes of percutaneous thermal with CT-guidance after artificial CO2 pneumothorax compared to US-guidance.